Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ST. LOUIS, March 5, 2013 /PRNewswire/ -- Sigma-Aldrich® Corporation (NASDAQ: SIAL) today announced that SAFC® (www.safcglobal.com), its custom manufacturing and services business unit, will expand its manufacturing plant in Irvine, Scotland to ...
read more
Advanced BioScience Laboratories announced it has been awarded a contract for "Preclinical and translational vaccine development for HIV and other candidate agents" by the Division of AIDS (DAIDS) within the National Institute of Allergy and ...
read more
Compile, a novel provider of life sciences data products, announced the launch of Multi-Payer Complete Claims ReadyData, a dataset that will allows life sciences and biotech companies to conduct more granular analyses, leading to more optimized drug ...
read more
Thursday, February 21, 2019
Dr. Reddy’s announced the re-launch of its Buprenorphine and Naloxone Sublingual Film, a therapeutic equivalent generic version of Suboxone sublingual film, in the U.S. market.
read more
Adimab has entered into an agreement with Eli Lilly to transfer the Adimab Platform to Lilly for the discovery and optimization of antibody-based drugs in all therapeutic areas.
read more
Monday, November 07, 2016
Amyris has entered into a research agreement with a commercial license option with one of the top 10 largest global pharmaceutical companies. Under the terms of the agreement, the collaboration will use Amyris's µPharmTM platform technology to ...
read more
BrainStorm has begun training City of Hope's Center for Biomedicine and Genetics to produce NurOwn adult stem cells for the ALS Phase 3 clinical study.
read more
Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, expects to double their lyophilization capacity for their fully automated, isolator-based filling line to meet new demand. A second lyophilizer will be added to the line ...
read more
Ardena announced it has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, NJ.
read more
Innovaderm announced a major rebranding to Indero. The new brand identity reinforces the company’s dual focus on rheumatology and dermatology and recognizes the close synergy between these fields.
read more
WindMIL Therapeutics have entered an agreement to expand WindMIL’s clinical manufacturing capacity.
read more
Thursday, December 18, 2014
Hovione today announced that the U.S. Food and Drug Administration (FDA) performed a Pre-Approval Inspection to its plant in Loures, Portugal, covering two NDA filings. At the conclusion of the inspection, the FDA issued a Form 483 with three ...
read more
PCI Synthesis announced the company’s president, Ed Price, has joined the Board of Governors of the Society of Chemical Manufacturers and Affiliates (SOCMA).
read more
Thursday, January 13, 2022
Procaps Group announced the closing of an asset purchase agreement to acquire an 86,000 sq. ft. pharmaceutical production facility located in Florida with production capacity of approximately 1.8 billion capsules per year.
read more
Wednesday, October 23, 2019
Dr. Reddy’s confirms it initiated a voluntary nationwide recall of all of its ranitidine medications sold in US due to confirmed contamination with NDMA above levels established by the FDA.
read more